SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-15-044316
Filing Date
2015-06-09
Accepted
2015-06-09 16:20:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a15-13639_1s3.htm S-3 399971
2 EX-2.2 a15-13639_1ex2d2.htm EX-2.2 6274
3 EX-5.1 a15-13639_1ex5d1.htm EX-5.1 38008
4 EX-23.1 a15-13639_1ex23d1.htm EX-23.1 2412
5 GRAPHIC g136391kgi001.jpg GRAPHIC 2395
  Complete submission text file 0001104659-15-044316.txt   451195
Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006
Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-204830 | Film No.: 15921151
SIC: 2834 Pharmaceutical Preparations